Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
about
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancerAdditional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patientsReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsA comparative analysis of antibody repertoire against Staphylococcus aureus antigens in patients with deep-seated versus superficial staphylococcal infectionsSystematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesCrystal Structures of Staphylococcus epidermidis Mevalonate Diphosphate Decarboxylase Bound to Inhibitory Analogs Reveal New Insight into Substrate Binding and CatalysisStructural Basis for Nucleotide Binding and Reaction Catalysis in Mevalonate Diphosphate DecarboxylaseStructures of sortase B from Staphylococcus aureus and Bacillus anthracis reveal catalytic amino acid triad in the active site.Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesEvolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina.Global regulation of Staphylococcus aureus genes by RotIdentification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis.Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.Efficacy of novel antibacterial compounds targeting histidine kinase YycG protein.In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections.Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) functionVancomycin resistance in staphylococci.Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureusPerformance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistanceNationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals.The standard one gram dose of vancomycin is not adequate prophylaxis for MRSAAccessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycinSafety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium sppAn elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus.Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.Linezolid in the treatment of Gram-positive prosthetic joint infections.Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia.Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery.Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria.Mechanisms of bacterial pathogenicity.Mechanisms of antibiotic resistance in Staphylococcus aureus.In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureusBiological properties of novel antistaphylococcal quinoline-indole agents.Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infectionAntimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis.High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands
P2860
Q24201136-D4017D27-5E30-456E-A1BF-F0B872A30840Q24246468-646404CF-2000-442A-95D2-DFA122B64AFDQ24646677-81071FE2-2630-4112-8C3C-3C72356F3B8BQ24817168-DE61E969-B060-4DDE-BA5B-BF5C3042CFE9Q26796560-BD728E61-8B64-4850-BE85-ECB290C0E12CQ27667799-029F489E-1938-4A08-9015-EFCF79D4D403Q27681397-79D33BF4-22AE-4176-86B9-80261C3DD661Q30163955-847D7397-1748-4015-AA92-D6EBF1AA64A5Q30341876-F8FA9AEA-586C-4EDD-BF28-540B8F77FE4DQ30352398-5B506A5B-8B2F-4A03-89FC-EFD2386A998FQ31123861-7F370D4A-6B6C-4A71-93BA-BD0AC1D0FA93Q32101683-4F33455F-EF11-41A2-ADCC-7128E282B849Q33261667-BBE26BB4-10D4-449D-9E81-84C5425E4A62Q33755387-4083A626-53B9-45A6-9F2A-7F3E6C142529Q33836677-1215C8EB-D399-40A8-8521-46B473887A68Q33883752-CA41D647-7A8B-4F95-9115-06E7704161E9Q33906522-003E80DC-3B95-4BE4-98A7-8523469F0667Q33935282-2F62DC86-EDBE-40E9-8E82-7A02936FA0AAQ33961588-80A31118-EE22-4EBE-B728-2AACF5A9EC8CQ33974326-404948E4-DD0A-4CB6-835D-208198DB64FAQ34024012-54E18602-7D7D-4439-B67A-E69160CE84F0Q34107062-1F9C6E86-E243-46A0-B00A-9429F3413D6DQ34123811-DC935B5E-5448-4354-8578-2A2725485557Q34141027-CA9EAB77-09D4-49C3-BC80-3F8312BCF01BQ34142416-5EC99156-D458-4614-9C04-5B613223DA03Q34308628-A2ACD73D-47CC-46C3-8ADA-814FA3ACA927Q34330270-37D3B9F5-8D54-4130-ABF3-BF0652444BE6Q34393206-28949C0D-A9F5-4A35-8684-177FDC1B3B8CQ34396414-37A50A06-ED82-477D-9F16-C5F09B4CE275Q34510414-5519C6A8-9385-44CC-9EEA-587C163D7A5BQ34582921-49EB9A13-0AC6-4155-90C0-ED911409B968Q34585655-3DA7E2B8-B21A-40CD-BB0F-BAB32E895A3EQ34657311-58AE5813-8488-4076-BFCE-C2FE64E7E817Q34721614-E74A7D07-0C97-456A-9CD2-1BC30EE8A4D0Q34721715-F6152CE1-6D26-4536-A27F-7B1B54EB6E17Q34747322-EC052FE8-6526-472A-BB8A-A4B32817691AQ34821242-192E8274-772B-4C7D-8CF3-3C06FEB1E96DQ34937444-429ED32E-3D98-49EC-909F-4E87178C7920Q34985828-77651642-4E25-4A2C-B975-7F5B065D4FD9Q35027895-40E04161-BB97-4EAC-B118-57D02AFA6F35
P2860
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@ast
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@en
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@nl
type
label
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@ast
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@en
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@nl
prefLabel
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@ast
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@en
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@nl
P2093
P2860
P921
P3181
P356
P1476
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
@en
P2093
F C Tenover
J W Biddle
M V Lancaster
P2860
P304
P3181
P356
10.3201/EID0702.010237
P407
P577
2001-01-01T00:00:00Z